FLT3 and acute myeloid leukemia: Specific high-risk mutations in AML, including FMS-like tyrosine kinase 3 (FLT3)-Internal Tandem Protein (ITD), abnormalities in chromosome 11, and inv(16) cytogenetic changes, are linked to a higher likelihood of CNS involvement [3].